Drugsmith Healthcare Private Limited
Sells cosmetics, drugs, health care products, food additives, and beauty products.
2021 | Ghaziabad, Uttar Pradesh (India) | Active
Drugsmith Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2022
About Drugsmith Healthcare
Drugsmith Healthcare Private Limited (DHPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 March 2021 (Three years and 11 months 16 days old ). Its registered office is in Ghaziabad, Uttar Pradesh, India.
The Company is engaged in the Consumer Goods Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sumit Singhal and Vipin Singhal serve as directors at the Company.
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85100UP2021PTC143455
- Company No.
143455
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Mar 2021
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Consumer Goods
Who are the key members and board of directors at Drugsmith Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumit Singhal  | Director | 13-Mar-2021 | Current |
| Vipin Singhal | Director | 13-Mar-2021 | Current |
Financial Performance of Drugsmith Healthcare.
Enhance accessibility to Drugsmith Healthcare's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Drugsmith Healthcare?
Unlock access to Drugsmith Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Drugsmith Pharmaceuticals Private LimitedSumit Singhal and Vipin Singhal are mutual person
- Svs Propbuild Private Limited
Sumit Singhal and Vipin Singhal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Drugsmith Healthcare?
Drugsmith Healthcare has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Drugsmith Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Drugsmith Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.